Rezultaty - Rotshteyn, Yakov
- Rezultaty 1 - 4 Rezultaty od 4
-
1
Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers od Gale, Donna Donigi, Landells, Linda J, Spina, Domenico, Miller, Alan J, Smith, Kate, Nichols, Terry, Rotshteyn, Yakov, Tonelli, Alfred, Lacouture, Peter, Burch, Ronald M, Page, Clive P, O'Connor, Brian J
Wydane 2002Text -
2
Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody od Jacobson, Jeffrey M., Thompson, Melanie A., Lalezari, Jacob P., Saag, Michael S., Zingman, Barry S., D’Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.
Wydane 2010Text -
3
Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture od Coburn, Glen A., Fisch, Danielle N., Moorji, Sameer M., de Muys, Jean-Marc, Murga, Jose D., Paul, Dorothy, Provoncha, Kathleen P., Rotshteyn, Yakov, Han, Amy Q., Qian, Dapeng, Maddon, Paul J., Olson, William C.
Wydane 2012Text -
4
Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults od Jacobson, Jeffrey M., Lalezari, Jacob P., Thompson, Melanie A., Fichtenbaum, Carl J., Saag, Michael S., Zingman, Barry S., D'Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.
Wydane 2010Text